SaveHealth reports on advancements in dementia medications, highlighting new treatments that modify disease progression and ...
A systematic review and meta-analysis of over 140 studies sheds light on which drug classes, including NMDA-receptor antagonists and VGSC blockers, can reduce secondary hyperalgesia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback